Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-05-27 @ 8:56 PM
Study NCT ID:
NCT05932667
Status:
TERMINATED
Last Update Posted:
2023-12-21
First Post:
2023-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Sponsor:
Organization: